High CD44 levels have been linked to cell proliferation and tumorigenesis in everything from solid tumors to hematologic malignancies, and siRNA knockdown of CD44 could significantly inhibit tumorigenicity [11]. The gene discussed is CD44; the disease is hematologic disorder.